unknown
Stage
3
Investors
About
Areteia Therapeutics was a clinical-stage biotechnology company developing oral treatments for respiratory conditions, specifically targeting eosinophilic asthma.
Explore Areteia Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.